Combining Real-World and Clinical Trial Data Through Privacy-Preserving Record Linkage: Opportunities and Challenges—A Narrative Review

IF 2.1 Q2 MEDICINE, GENERAL & INTERNAL
Michael Batech, Ann Madsen, Nicolle Gatto, Tancy C. Zhang, Deborah Ricci, Raymond Harvey, Najat Khan, Sid Jain
{"title":"Combining Real-World and Clinical Trial Data Through Privacy-Preserving Record Linkage: Opportunities and Challenges—A Narrative Review","authors":"Michael Batech,&nbsp;Ann Madsen,&nbsp;Nicolle Gatto,&nbsp;Tancy C. Zhang,&nbsp;Deborah Ricci,&nbsp;Raymond Harvey,&nbsp;Najat Khan,&nbsp;Sid Jain","doi":"10.1002/hsr2.71272","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background and Aims</h3>\n \n <p>Despite their widespread use, randomized clinical trials (RCTs) face challenges like differential loss to follow-up, which can impact validity. Real-world evidence (RWE) from real-world data (RWD) is increasingly used to address these limitations, but RCTs and RWE have provided complementary, disconnected observations of the patient journey. Privacy-preserving record linkage (PPRL) enables the integration of patient records across these data sources. This narrative review explores the potential use cases of PPRL to overcome the limitations of both RCTs and RWD for clinical research and regulatory decision-making.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>This manuscript is a narrative review and did not involve the collection or analysis of primary research data. The authors aimed for comprehensive topic coverage and a synthesis of key concepts from the current literature, rather than adhering to a formal systematic review protocol (e.g., PRISMA).</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>PPRL can generate a more comprehensive understanding of patient interaction with the healthcare system. For example, long-term information about participants before and after a trial can assist in identifying predictors of drug response or intolerance, reducing patient burden, and providing alternatives to traditional study designs. Linked data applications include expanding patient health histories and creating comprehensive patient data repositories that enable innovative trial designs. However, opportunities remain to demonstrate the provenance, quality, and completeness of RWD sources to ensure scientific rigor.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Combining RCTs and RWD through PPRL offers significant and insufficiently explored potential for advancing drug development research, reducing operational costs, and enhancing data availability. Further consideration of PPRL use cases may drive innovative trial designs augmented with RWD, improving the ability of this collected data to support informed decision-making.</p>\n </section>\n </div>","PeriodicalId":36518,"journal":{"name":"Health Science Reports","volume":"8 9","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/hsr2.71272","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Science Reports","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/hsr2.71272","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background and Aims

Despite their widespread use, randomized clinical trials (RCTs) face challenges like differential loss to follow-up, which can impact validity. Real-world evidence (RWE) from real-world data (RWD) is increasingly used to address these limitations, but RCTs and RWE have provided complementary, disconnected observations of the patient journey. Privacy-preserving record linkage (PPRL) enables the integration of patient records across these data sources. This narrative review explores the potential use cases of PPRL to overcome the limitations of both RCTs and RWD for clinical research and regulatory decision-making.

Methods

This manuscript is a narrative review and did not involve the collection or analysis of primary research data. The authors aimed for comprehensive topic coverage and a synthesis of key concepts from the current literature, rather than adhering to a formal systematic review protocol (e.g., PRISMA).

Results

PPRL can generate a more comprehensive understanding of patient interaction with the healthcare system. For example, long-term information about participants before and after a trial can assist in identifying predictors of drug response or intolerance, reducing patient burden, and providing alternatives to traditional study designs. Linked data applications include expanding patient health histories and creating comprehensive patient data repositories that enable innovative trial designs. However, opportunities remain to demonstrate the provenance, quality, and completeness of RWD sources to ensure scientific rigor.

Conclusion

Combining RCTs and RWD through PPRL offers significant and insufficiently explored potential for advancing drug development research, reducing operational costs, and enhancing data availability. Further consideration of PPRL use cases may drive innovative trial designs augmented with RWD, improving the ability of this collected data to support informed decision-making.

Abstract Image

通过隐私保护记录链接结合现实世界和临床试验数据:机遇和挑战-叙述性回顾
背景和目的尽管随机临床试验(RCTs)被广泛使用,但它面临着诸如随访差异损失等挑战,这可能会影响有效性。来自真实世界数据(RWD)的真实世界证据(RWE)越来越多地用于解决这些局限性,但rct和RWE提供了互补的、不相关的患者旅程观察。隐私保护记录链接(PPRL)支持跨这些数据源集成患者记录。这篇叙述性综述探讨了PPRL的潜在用例,以克服rct和RWD在临床研究和监管决策中的局限性。方法本文是一篇叙述性综述,不涉及原始研究数据的收集和分析。作者的目标是全面的主题覆盖和当前文献中的关键概念的综合,而不是坚持正式的系统审查方案(例如,PRISMA)。结果PPRL可以更全面地了解患者与医疗保健系统的相互作用。例如,试验前后参与者的长期信息有助于确定药物反应或不耐受的预测因素,减轻患者负担,并为传统研究设计提供替代方案。关联数据应用程序包括扩展患者健康历史和创建全面的患者数据存储库,从而实现创新的试验设计。然而,仍然有机会证明RWD来源的来源、质量和完整性,以确保科学的严谨性。结论通过PPRL将rct和RWD结合起来,在推进药物开发研究、降低运营成本和增强数据可用性方面具有重要的潜力,但尚未得到充分的探索。对PPRL用例的进一步考虑可能会推动与RWD相结合的创新试验设计,提高收集数据的能力,以支持明智的决策。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Health Science Reports
Health Science Reports Medicine-Medicine (all)
CiteScore
1.80
自引率
0.00%
发文量
458
审稿时长
20 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信